Calcium antagonists prevent early post-infarction ventricular fibrillation

Area of Science:

• Cardiovascular Pharmacology
• Experimental Cardiology

Background:

• Acute coronary artery ligation in rats is a model for studying ventricular arrhythmias.
• Ventricular arrhythmias, including tachycardia and fibrillation, are serious complications following myocardial infarction.

Purpose of the Study:

• To evaluate the efficacy of nifedipine and nisoldipine in preventing or treating ventricular arrhythmias induced by acute coronary artery ligation in rats.
• To assess the potential of these calcium channel blockers as prophylactic agents against sudden cardiac death.

Main Methods:

• Intravenous administration of nifedipine (5-50 microgram/kg) or nisoldipine (5-1000 microgram/kg) to pentobarbitone-anesthetized rats.
• Induction of acute coronary artery ligation to trigger ventricular arrhythmias.
• Monitoring and quantification of ventricular tachycardia, fibrillation, and ectopic activity.

Main Results:

• Both nifedipine and nisoldipine markedly reduced or abolished serious ventricular arrhythmias post-ligation.
• Nifedipine and a lower dose of nisoldipine significantly decreased ventricular ectopic activity.
• The highest dose of nisoldipine also showed a significant reduction in ventricular ectopic activity.

Conclusions:

• Nifedipine and nisoldipine demonstrate significant efficacy in managing experimental ventricular arrhythmias.
• These calcium channel blockers show promise for prophylactic use to mitigate sudden cardiac death risk in post-myocardial infarction patients.